Form 8-K - Current report:
SEC Accession No. 0001564590-20-021927
Filing Date
2020-05-06
Accepted
2020-05-06 16:10:18
Documents
3
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20200505.htm 8-K 31300
2 EX-99.1 arav-ex991_6.htm EX-99.1 124675
3 GRAPHIC g0hcrvftsenp000001.jpg GRAPHIC 2563
  Complete submission text file 0001564590-20-021927.txt   160877
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 20852695
SIC: 2834 Pharmaceutical Preparations